VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 185 filers reported holding VIKING THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,167,850 | -30.4% | 557,168 | +1.9% | 0.00% | 0.0% |
Q2 2023 | $8,859,299 | +20191.6% | 546,533 | +20617.7% | 0.00% | – |
Q1 2023 | $43,660 | +1091400.0% | 2,638 | +429.7% | 0.00% | – |
Q4 2022 | $4 | -100.0% | 498 | -98.3% | 0.00% | – |
Q3 2022 | $80,000 | -40.3% | 29,008 | -37.1% | 0.00% | – |
Q2 2022 | $134,000 | +35.4% | 46,085 | +40.1% | 0.00% | – |
Q1 2022 | $99,000 | -20.2% | 32,893 | +20.5% | 0.00% | – |
Q4 2021 | $124,000 | -24.4% | 27,287 | +4.4% | 0.00% | – |
Q3 2021 | $164,000 | +2.5% | 26,135 | -2.7% | 0.00% | – |
Q2 2021 | $160,000 | -36.3% | 26,872 | -31.8% | 0.00% | – |
Q1 2021 | $251,000 | +50.3% | 39,423 | +32.3% | 0.00% | – |
Q4 2020 | $167,000 | +15.2% | 29,800 | +21.9% | 0.00% | – |
Q3 2020 | $145,000 | -8.8% | 24,442 | +10.8% | 0.00% | – |
Q2 2020 | $159,000 | +57.4% | 22,052 | +2.8% | 0.00% | – |
Q1 2020 | $101,000 | -41.3% | 21,455 | +0.1% | 0.00% | – |
Q4 2019 | $172,000 | +17.0% | 21,435 | 0.0% | 0.00% | – |
Q3 2019 | $147,000 | -1.3% | 21,435 | +20.3% | 0.00% | – |
Q2 2019 | $149,000 | +0.7% | 17,824 | +20.1% | 0.00% | – |
Q1 2019 | $148,000 | +26.5% | 14,841 | -3.1% | 0.00% | – |
Q4 2018 | $117,000 | -44.0% | 15,320 | +27.5% | 0.00% | – |
Q3 2018 | $209,000 | +148.8% | 12,011 | +35.8% | 0.00% | – |
Q2 2018 | $84,000 | – | 8,843 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |